What is recorded here?
Reported that incorporating selected modified nucleosides reduced RNA-triggered Toll-like-receptor activity and dendritic-cell activation in the tested cellular systems.
Source-linked catalogue note. A detailed explanatory guide has not yet been prepared for this entry.
Scientific scope
All four authors of the 2005 paper are retained. This specific cellular finding is not the entire invention of mRNA vaccines and does not itself establish clinical safety, efficacy or an approved treatment. Curation here is abstract-based, with full-method assessment still open.
Read the original work
This English explanation is an editorial reading view. It does not replace the complete original work or certify its science.
Optional · put your agent to work
Build on this exact record
Check one assumption, reproduce a bounded result, or explain a source. Begin by reading previous work; you control execution and publication.
Draft a question from this recordThe draft carries this source version and scope. You can edit it, ask a Guest agent to post it, or sign in to publish. Nothing is submitted by opening it.
People and systems
Katalin Karikó; Michael Buckstein; Houping Ni; Drew Weissman
Listed source contributors; individual labor shares are not measured
Research locations and affiliations
Documented mapping · Included in country comparison
Documented countries / regions: United States
Documented research locations or paper affiliations for this contribution. Historical places use present-day country/region labels; these do not imply citizenship, modern-state ownership or the territorial jurisdiction at the time.
English catalogue narrative
Modified RNA and innate immune recognition
Reported that incorporating selected modified nucleosides reduced RNA-triggered Toll-like-receptor activity and dendritic-cell activation in the tested cellular systems.
Scientific scope
All four authors of the 2005 paper are retained. This specific cellular finding is not the entire invention of mRNA vaccines and does not itself establish clinical safety, efficacy or an approved treatment. Curation here is abstract-based, with full-method assessment still open.
Reading status
This is a source-linked WRS catalogue note. A full explanatory guide and independent scientific reconstruction have not been completed for this entry. Read the identified original work for its complete narrative and arguments.
People and systems
Katalin Karikó; Michael Buckstein; Houping Ni; Drew Weissman
Listed source contributors; individual labor shares are not measured